TLDR Spironolactone successfully treated hair loss in a 9-year-old girl.
This case report describes the successful treatment of female-pattern hair loss (FPHL) in a 9-year-old girl with spironolactone. FPHL is a common disorder affecting 30% of Australian women, but rare in prepubescent children. The patient had a 6-month history of increasing hair shedding and generalized hair thinning, with a midline clinical grade of 2. After 6 months of treatment with spironolactone at a dose of 100 mg orally per day, the patient had a noticeable narrowing of the midline part consistent with a midline clinical grade of 1. Spironolactone is an aldosterone antagonist used in the treatment of hypertension, but it also possesses anti-androgenic properties, acting as an androgen receptor antagonist and reducing the levels of cytochrome P450-dependent enzymes 173-hydroxylase and desmolase, which are both required for androgen synthesis. Spironolactone has been shown to be safe and effective in the treatment of FPHL in adults and well tolerated at a dose of 200 mg orally per day. The authors suggest that this treatment should be considered in other cases of prepubertal FPHL.View this study on onlinelibrary.wiley.com →
Hair loss severity relates to increased miniaturization in female pattern hair loss.
Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.
Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.
AGA can occur in children with family history; early diagnosis and treatment important.
Trichoscopy is good for diagnosing and monitoring hair and scalp problems in children but needs more research for certain conditions.
Spironolactone successfully treated hair loss in a 9-year-old girl.
Spironolactone and minoxidil together effectively treat female pattern hair loss.